Hirotetsu Takagi
Kashihara-shi, 6348522, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Clinical Significance of Serum Zinc Levels on the Development of Sarcopenia in Cirrhotic Patients.
Journal: Cancer diagnosis & prognosis
Published: November 24, 2021
The Combination of Albumin-Bilirubin Score and Prothrombin Time Is a Useful Tool for Predicting Liver Dysfunction after Transcatheter Arterial Chemoembolization in Child-Pugh Class A Patients with Hepatocellular Carcinoma within Up-to-Seven Criteria.
Journal: Journal of clinical medicine
Published: September 09, 2021
Clinical Significance of Gamma-Glutamyltranspeptidase Combined with Carbohydrate-Deficient Transferrin for the Assessment of Excessive Alcohol Consumption in Patients with Alcoholic Cirrhosis.
Journal: Medicines (Basel, Switzerland)
Published: July 03, 2021
The Angiotensin II Receptor Blocker Losartan Sensitizes Human Liver Cancer Cells to Lenvatinib-Mediated Cytostatic and Angiostatic Effects.
Journal: Cells
Published: February 15, 2021
Small intestinal follicular lymphoma induced by methotrexate: a case report.
Journal: BMC gastroenterology
Published: January 16, 2021
The association between sarcopenia and endotoxin in patients with alcoholic cirrhosis.
Journal: Medicine
Published: December 24, 2020
Lenvatinib prevents liver fibrosis by inhibiting hepatic stellate cell activation and sinusoidal capillarization in experimental liver fibrosis.
Journal: Journal of cellular and molecular medicine
Published: September 29, 2020
Accuracy of Fibrosis-4 Index in Identification of Patients with Cirrhosis Who Could Potentially Avoid Variceal Screening Endoscopy.
Journal: Journal of clinical medicine
Published: September 28, 2020
Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS/TLR4 signaling pathway.
Journal: The Journal of nutritional biochemistry
Published: June 30, 2020
Thyroid-stimulating hormone is an independent risk factor of non-alcoholic fatty liver disease.
Journal: JGH open : an open access journal of gastroenterology and hepatology
Published: August 20, 2019
Last Updated: 09/26/2026